Therefore, the mechanism by which IDO2 regulates IMQ-induced dermatitis might not be associated with tryptophan metabolites, and our results on the metabolites might just reflect the consequences of inflammation caused by IMQ treatment. The gene discussed is IDO2; the disease is dermatitis.